[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []